Clinical trial
An Open Label Pilot Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment of Moderate to Severe Facial Acne
NCT00725439 is registered in ClinicalTrials.gov with Stiefel, a GSK Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Pilot Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment of Moderate to Severe Facial Acne
- Lead sponsor
- Stiefel, a GSK Company
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2004
- Completion date
- December 31, 2007
- Enrollment
- 16 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
acne